MedPath

Clinical observation on the therapeutic effect of 'three-part acupoint combination' combined with Aili eye drops in the treatment of perimenopausal dry eye syndrome.

Phase 1
Recruiting
Conditions
dry eye disease
Registration Number
ITMCTR2000003938
Lead Sponsor
Shanghai General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) Meet the above diagnostic criteria of perimenopausal dry eye with deficiency of liver and kidney Yin;
(2) If the western medicine eye drops are used for treatment before enrollment, the drug should be stopped for at least three weeks or more; in addition, the patient has not participated in other therapies or other clinical studies within three months;
(3) Non-allergic constitution;
(4) Voluntary participation and signing of informed consent.

Exclusion Criteria

(1) Patients with other eye diseases, such as congenital tear deficiency, lacrimal duct obstruction, severe trachoma, keratopathy, conjunctival scarring, conjunctival lesions and other eye diseases, and subjects undergoing eye surgery;
(2) Combined with dry mouth, joint pain and dry skin, considered as sjogren's syndrome caused by dry eyes;
(3) Subjects during pregnancy and lactation;
(4) Subjects with severe systemic diseases, such as cardiovascular and cerebrovascular diseases, severe liver and kidney dysfunction, and coagulation dysfunction;
(5) Subjects with mental disorders or psychological disorders who cannot cooperate with the treatment and study;
(6) Contact lens wearer.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
BUT;FL;Schirmer test;
Secondary Outcome Measures
NameTimeMethod
sex hormone;
Âİ Copyright 2025. All Rights Reserved by MedPath